SpringWorks Therapeutics Inc

SpringWorks Therapeutics Inc

SWTX - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$3.54B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
SpringWorks Therapeutics IncSpringWorks Therapeutics Inc-13.5--61%23.50.1
$-38.60

Current Fair Value

182.1% downside

Overvalued by 182.1% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$3.54 Billion
Enterprise Value$3.50 Billion
Earnings per Share$-3.48
Beta0.7
Outstanding Shares74,885,348

Return

Return on Equity-60.84%ROE
Return on Assets-50.25%
Return on Invested Capital-62.57%

Valuation & Multiples

P/E Ratio-13.5P/E Ratio
PEG281.07PEG
Price to Sales23.5Price to Sales
Price to Book Ratio9.4Price to Book Ratio
Enterprise Value to Revenue15.93
Enterprise Value to EBIT-13.22
Enterprise Value to Net Income-14
Total Debt to Enterprise0.01
Debt to Equity0.05Debt to Equity

Revenue Sources

No data

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.09, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.0895▼ 35.07%
Total Calls9,323,649▲ 61.25%
Total Puts834,300▼ 67.22%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %100.34%▲ 1.92%
Total Invested$3.53B▲ 8.48%
Investors Holding248▼ 103.00%

About SpringWorks Therapeutics Inc

SpringWorks Therapeutics Insider Information FAQ

In the latest 13F quarter on Stockcircle, 6 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.